First Eagle Investment Management, LLC
Position in WRBY — Warby Parker Inc.
CIK 1325447
NEW YORK, NY
Position in WRBY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,846,346
-$4,844,238 QoQ
Shares Held
135,090
-61.7% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in WRBY Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Mar 31, 2026First Eagle Investment Management, LLC holds $2,073,277,294 across 7 Medical Instruments & Supplies names. WRBY ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BDX |
Becton Dickinson & Co
|
11,928,111 | $1,875,456,891 | |
| 2 | XRAY |
DENTSPLY SIRONA Inc.
|
15,127,933 | $175,484,022 | |
| 3 | ATRC |
AtriCure, Inc.
|
262,143 | $7,478,939 | |
| 4 | NVST |
Envista Holdings Corp
|
264,500 | $6,710,365 | |
| 5 | ANGO |
Angiodynamics Inc
|
275,735 | $3,135,106 | |
| 6 | WRBY |
Warby Parker Inc.
This page
|
135,090 | $2,846,346 | |
| 7 | STVN |
Stevanato Group S.p.A.
|
157,500 | $2,165,625 |
All Filings in WRBY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,846,346 | 135,090 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,690,584 | 352,941 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $15,159,098 | 549,641 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,305,887 | 561,144 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $7,657,948 | 420,074 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,559,765 | 312,258 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $571,223 | 34,980 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $131,033 | 8,159 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||